United Therapeutics reported $315.9M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Amarin AMRN:US USD 287.36M 74.22M
Ardelyx ARDX:US USD 51.95M 3.25M
Baxter International BAX:US USD 3.71B 208M
Bayer BAYN:GR EUR 33.17B 471M
Biogen BIIB:US USD 3.93B 1.09B
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Emergent Biosolutions EBS:US USD 268.4M 8.3M
Esperion Therapeutics ESPR:US USD 82.34M 70K
Gilead Sciences GILD:US USD 10.42B 1.2B
GlaxoSmithKline GSK:LN GBP 20.95B 16.88B
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Insmed INSM:US USD 137.65M 23.84M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Intra Cellular Therapies ITCI:US USD 77.41M 6.78M
Lexicon Pharmaceuticals LXRX:US USD 18.44M 1.58M
Moderna Inc MRNA:US USD 6.81B 5M
Omeros OMER:US USD 39.51M 1.01M
Ptc Therapeutics PTCT:US USD 420.08M 147.29M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Sangamo Biosciences SGMO:US USD 122.36M 2.37M
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Seattle Genetics SGEN:US USD 726M 117.48M
Teva Pharmaceutical TEVA:IT USD 11.53B 538M
United Therapeutics UTHR:US USD 315.9M 15.6M
Vertex Pharmaceuticals VRTX:US USD 2.61B 53.1M